Why is MiMedx Group, Inc. ?
- ROCE(HY) Lowest at 13.77%
- RAW MATERIAL COST(Y) Grown by 13.82% (YoY)
- NET SALES(Q) Lowest at USD 58.99 MM
- Along with generating -37.80% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is MiMedx Group, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 70.59 MM
Lowest at -58.53 %
Highest at USD 325.89 MM
Highest at 2.96 times
Highest at 7.19 times
Lowest at 13.77%
Grown by 13.82% (YoY
Lowest at USD 58.99 MM
Lowest at USD -14.43 MM
Lowest at -24.46 %
Lowest at USD -15.33 MM
Lowest at USD -10.86 MM
Lowest at USD -0.07
Here's what is working for MiMedx Group, Inc.
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Cash and Cash Equivalents
Inventory Turnover Ratio
Debtors Turnover Ratio
Here's what is not working for MiMedx Group, Inc.
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Raw Material Cost as a percentage of Sales






